News Archives - Tethis

News

March 10, 2025

Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer

Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer…

Rossana Roncarolo

News

January 14, 2025

Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy

Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods…

Rossana Roncarolo

News

September 3, 2024

Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage…

Rossana Roncarolo

News

April 2, 2024

Tethis S.p.A. announces enrollment of the first two patients in a clinical study of its See.d platform which allows automated standardized plasma and cell sample preparation for multiomic liquid biopsy

Tethis S.p.A. announces enrollment of the first two patients in a clinical study of its…

Mariagiulia

News

October 20, 2022

Tethis appoints Holger Neecke as the company’s Chief Executive Officer

Tethis appoints Holger Neecke as the company's Chief Executive Officer MILAN, Oct. 20, 2022 /PRNewswire/ -- Tethis…

Mariagiulia

News

May 16, 2022

Tethis launches See.d®, the first fully automated, standardized pre-analytical platform for comprehensive liquid biopsy testing

Tethis launches See.d®, the first fully automated, standardized pre-analytical platform for comprehensive liquid biopsy testing…

Mariagiulia

News

July 19, 2021

Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board of Directors

Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board…

admin

News

March 24, 2021

Study published in BJC shows strong performance of Tethis’ liquid biopsy test in early stage breast cancer

Tethis S.p.A announced the publication of a pilot study in early breast cancer showing the…

admin

News

December 17, 2020

Tethis’ SAB appoints Prof. Aceto, Ph.D, as Chairman

Tethis S.p.A announced today that in the first meeting of the reconfirmed Scientific Advisory Board…

admin

News

Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer

Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy

Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. announces enrollment of the first two patients in a clinical study of its See.d platform which allows automated standardized plasma and cell sample preparation for multiomic liquid biopsy

Tethis appoints Holger Neecke as the company’s Chief Executive Officer

Tethis launches See.d®, the first fully automated, standardized pre-analytical platform for comprehensive liquid biopsy testing

Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board of Directors

Study published in BJC shows strong performance of Tethis’ liquid biopsy test in early stage breast cancer

Tethis’ SAB appoints Prof. Aceto, Ph.D, as Chairman

Recent Posts

Recent Comments